Author's posts
How CMS is affecting the future of healthcare
From the dismissal of the inpatient-only list to the removal of procedures from the ASC-payable list, CMS plays a massive role in the success of an ASC.
The next GI trend: More advanced-stage cancer
As the COVID-19 pandemic demanded all hands on deck in the medical community, and patients put off preventive care, many other medical services fell by the wayside. The resulting ripple effects may be felt for years to come.
Virginia eye practice bought by private equity-backed group
Fredericksburg, Va.-based Vista Eye Specialists was acquired by Richmond, Va.-based Atlantic Vision Partners, which is backed by private equity firm Sheridan Capital Partners.
Certificate of need laws in 2022 | 6 things to know
Certificate of need laws are the strongest correlation to the number of ASCs per capita in a state, according to an analysis by Becker’s.
24% of physicians say prior authorization wait led to hospitalization of patient
Thirty-four percent of physicians reported that delays in processing a prior authorization led to a serious adverse event for a patient in their care, according to a recent survey from the American Medical Association.
Ambulatory romance: Vasectomies for Valentine’s
Flowers, chocolates, diamonds and dinner dates are all perfectly fine, if a bit typical, for a Valentine’s Day gift. Far more original is the husband who goes a different route: Booking the most romantic outpatient surgery of all.
Mednax closes $1.1B in financing
Sunrise, Fla.-based medical group Mednax closed its issuance of $400 million in aggregate principal amount of senior notes in a private offering, the company said Feb. 11.
2 law firms get $12M in Surgery Partners’ $45M settlement
Law firms Heyman Enerio Gattuso & Hirzel and Block & Leviton were awarded around $12.2 million in fees Feb. 11 in connection with Surgery Partners’ $45 million settlement, according to Law360.
New model predicts treatment response of chemotherapy, immunotherapy for gastric cancer
A new model could help determine a patient’s most effective treatment option for gastric cancer.
Motus GI wins FDA nod for colonoscopy device
The FDA granted Motus GI market clearance for its second-generation Pure-Vu EVS system.
